Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Jujo (Chiba, Japan), N. Tanabe (Narashino, Japan), K. Hosomi (Osaka, Japan), H. Shoji (Chiba, Japan), J. Park (Osaka, Japan), Y. Ikubo (Chiba, Japan), A. Yanagisawa (Chiba, Japan), T. Kobayashi (Chiba, Japan), K. Yamamoto (Chiba, Japan), H. Miwa (Chiba, Japan), A. Naito (Chiba, Japan), H. Kasai (Chiba, Japan), R. Suda (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Sugiura (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Mizuguchi (Osaka, Japan), J. Kunisawa (Osaka, Japan), K. Tatsumi (Chiba, Japan). Late Breaking Abstract - The effect of altering gut microbiota on the development of pulmonary hypertension. 3950

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Disturbance of the core microbiota in transplanted lung associates with sub- or excessive control of host immunity Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Late Breaking Abstract - Effects of tezepelumab on host epithelial tolerance to virus in patients with uncontrolled asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Altered gut microbiota in chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease. Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Pulmonary arterial hypertension-associated changes in gut pathology and microbiota Source: ERJ Open Res, 6 (3) 00253-2019; 10.1183/23120541.00253-2019 Year: 2020 Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Late Breaking Abstract - Implication of the KATP Sur2b/Kir6.1 in the physiopathology of pulmonary arterial hypertension Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Molecular mechanisms involved in early stage of pulmonary hypertension: experimental study Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Late Breaking Abstract - Formaldehyde inhalation impairs immune system and may affects severity of allergic disease Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013